2,6-Bis[(o-hydroxy)phenyliminomethyl]-1-hydroxybenzene as a reagent for the selective spectrofluorimetric determination of aluminium

A spectrofluorimetric method for the determination of aluminium at ng/ml level has been developed. The method is based on the formation of a fluorescent 11 complex between Al(III) and 2,6-bis[(o-hydroxy)phenyliminomethyl]-1-hydroxybenzene at an apparent pH of 5.0 in an aqueous-ethanol medium (70% v/v ethanol). The influence of reaction variables is discussed. The range of concentration of the method is 1.0–10.0 ng/ml aluminium, the relative standard deviation 1.5% and the limit of detection 0.1 ng/ml. The advantages of the proposed method include high sensitivity and selectivity. The method has been applied to the determination of aluminium in natural waters.     

Determination of Nucleic Acids Using Rivanol as the Fluorescent Probe in the Presence of SDS

ABSTRACT

The quantitative method for nucleic acids using rivanol as the fluorescent probe in the presence of SDS was proposed. Under proper conditions, addition of nucleic acids to a mixture of rivanol and SDS resulted in enhanced fluorescence and spectral shifts of rivanol-SDS system. The calibration graph was linear in the range of 0–10.0 μg/ml for CT DNA and 0–9.0 μg/ml for yeast RNA, the limit of detection was 62 ng/ml for CT DNA and 156 ng/ml for yeast RNA. CT DNA could be determined in the presence of 20%(w/w) yeast RNA.     

Sensitive Determination of Piritramide in Human Plasma by High-Performance Liquid Chromatography

Abstract

A selective and sensitive method for the determination of piritramide in human plasma is described. After addition of 50 μl of 2 M ammonia and 20 μl of aqueous promethazine solution (100 ng/10 μ1) as an internal standard, 1 ml of plasma was extracted with 5 ml of toluene (extraction efficiency: 93.9 × 2.6%; mean × S. D.; n = 5). HPLC was performed with a phenyl hypersil NC-04 column, particle size 5 μm, 250 × 4 mm I. D.; mobile phase: 8 parts of acetonitrile and 2 parts of 10 mM potassium phosphate buffer (pH 3. 3). The flow rate was set to 2 ml/min and the column temperature was 22°C. The assay was linear in a concentration range of 3.75 ? 3000 ng/ml (r = 0.999), with a lower limit of detection of 3 ng/ml. The precision was determined using spiked plasma samples (15 ng/ml; 300 ng/ml), with coefficients of variation of 6.1 and 5.9% (intraday; n = 5) and 6.5 and 0.2% (interday; n = 3). In the range of 5.6 ? 1500 ng/ml, the accuracy of the assay was 2.82%. The method was used for the determination of piritramide plasma concentrations in patients receiving intra- or postoperative analgesia.     

An Enzyme-Linked Immunosorbent Assay (Elisa) for Measurement of Human Igg Subclass Levels in Serum

Abstract

We established an enzyme-linked immunosorbent assay (ELISA) to quantify human IgG subclasses in serum. IgG subclasses captured with subclass-specific mouse MoAbs could be detected with enzyme-labeled goat anti-human IgG. We screened the MoAbs which were suitable for the method from the commercially available MoAbs raised against human IgG subclasses. The specificity of the present ELISA for each subclass was clarified by the experiments as follows: (a) identification of individual IgG subclasses purified from total IgG by protein A column chromatography and (b) identification of a certain specific subclass which increased relatively in monoclonal (M)-proteinemia-patient sera compared with normal. We could detect each subclass with the sensitivity of 4.0 ng/ml for IgG₁, 13 ng/ml for IgG₂, 0.5 ng/ml for IgG₃ and 0.4 ng/ml for IgG₄ using pooled normal serum calibrated against a reference serum 67/86 from the World Health Organization (WHO) as a standard.     

ETAAS determination of aluminium and copper in dialysis concentrates after microcolumn chelating ion-exchange preconcentration

A procedure was developed for the preconcentration and determination of aluminium and copper in dialysis concentrates at the ng cm^–3 level. The preconcentration was achieved on microcolumns filled with Chelex-100 resin adjusted to a pH of 4.0. Five repetitive cycles of the sample through the column ensured a sufficient contact time for quantitative retention of aluminium and copper ions. The retained ions were eluted with HNO₃ (0.5 mol dm^–3). Aluminium and copper were determined in the eluate by Zeeman ETAAS using the standard addition technique. The procedure was performed under clean room conditions (class 10,000), The reliability of the results was evaluated by recovery tests, using dialysis concentrates spiked with aluminium and copper. The recoveries obtained ranged from 86 to 106% for aluminium and from 92 to 97% for copper. Using the recommended procedure, the LOD of aluminium and copper in dialysis concentrates (preconcentration factor 2) was found to be 0.5 ng cm^–3 and 0.2 ng cm^–3, respectively. Received: 19 December 1997 / Revised: 10 March 1998 / Accepted: 28 March 1998     

Determination of Formaldehyde in Waste Water by Lucigenin Chemilummescence

Abstract

A chemiluminescence analysis has been developed for the determination of formaldehyde based on its inhibition of the chemiluminescence reaction of lucigenin-C10^?-H₂o₂. The method is sensitive, convenient and selective with a detection limit of 0.05ng/ml. The linear dynamic range is 1.0ng/ml to 0.1 μg/ml. The variation coefficient of ten determinations for 2.Ong/ml formaldehyde is 1.2%. Applications to the trace determination of formaldehyde in industrial waste waters are discussed.     

Determination of Pyridostigmine in Human Plasma by High-Performance Liquid Chromatography

Abstract

An easy to perform, specific, reproducible and sensitive high performance liquid chromatographic (HPLC) method to measure pyridostigmine concentration in human plasma was developed and validated. Sample clean-up consists of ion-pair extraction into dichloromethane in the presence of neostigmine as internal standard, followed by back extraction into an aqueous phase. Mean recovery of 110% (with a standard deviation of 10%) was determined for concentrations of 5 – 100 ng/ml. Chromatography on a 125·4 mm CN-propyl column using a mobile phase composed of 10% acetonitrile in 3.5×10^?4M NaH₂PO₄ and UV detection at 270 nm, yields clean chromatograms without any interferences from endogenous plasma components. Using 1 ml plasma samples the method has a limit of detection (LD) of 3 ng/ml, with %CV (precision) and bias (accuracy) ≥ 10% for concentrations in the range of 0–100 ng/ml. The method is being used in human pharmacokinetic studies of oral dosage forms of pyridostigmine.     

HPLC Determination of Ochratoxin A in a Low Volume of Human Blood Serum

Abstract

A high‐performance liquid chromatography (HPLC) method has been developed for the determination of ochratoxin A (OTA) in human blood serum. Samples were purified on a C18 solid phase extraction column. The developed method required a relatively low serum volume (0.5 ml). Significant correlation (r of 0.998) was found over the range from 0.10 to 8 ng/ml, with a detection limit of 0.1 ng/ml and better performance in terms of precision and accuracy. Mean recoveries at 0.5 and 2 ng/ml were respectively 69.7±1.2 and 71.9±2.8%. This method was used as a rapid and noninvasive tool to assess human exposure to OTA. Among 40 analyzed serum samples, 27.5% were found to contain OTA with levels going from 0.1 to 11.98 ng/ml with a mean concentration of 0.73±2.35 ng/ml.     

High Sensitive and Selective Spectrophotometric Determination of Aluminium after Collection on a Membrane Filter Using 2,3‐Dichloro‐6‐(3‐carboxy‐2‐hydroxy‐1‐naphthylazo)quinoxaline and Zephiramine

Abstract

A high sensitive and selective spectrophotometric method for the determination of aluminium(III) using 2,3‐dichloro‐6‐(3‐carboxy‐2‐hydroxy‐1‐naphthylazo)quinoxaline (DCHNAQ) and zephiramine (zeph) is described. The formed ion pair precipitate between zephiramine and perchlorate ions is effective for the enrichment of aluminium(III) on a membrane filter as its ternary complex with DCHNAQ and zephiramine. The solid–state absorbance of the complex on the membrane filter is measured at 655 nm against a blank thin layer and the difference is calculated. The colour system obeys Beer's law from 5.0–150 ng ml^?1 of aluminium. The detection and quantification limits were calculated. The relative standard deviation for 60 ng of aluminium(III) in 20‐ml sample volume amounts 0.84% (n=10). A ligand buffer solution, composed of transcyclohexane‐1,2‐diaminetetraacetic acid with an excess of zinc(II), is effective for masking interferences from foreign ions, particularly iron(III). The proposed method was applied successfully to tap and environmental water, biological (human blood, urine, and gallstone), and soil samples.     

The Determination of a New Trifluorinated Quinolone,Fleroxacin, Its N-Demethyl,and N-Oxide Metabolites in Plasma and Urine by High Performance Liquid Chromatography with Fluorescence Detection

Abstract

A liquid chromatographic method is described for the determination of the new fluoroquinolone Ro 23–6240 and its N-demethyl and N-oxide metabolites in plasma and urine. The three substances were extracted from aqueous solution with dichloromethane/isopropanol containing sodium dodecyl sulphate. After evaporation and reconstitution, samples were analysed on a reversed-phase column using ion pair chromatography and fluorescence detection. The limit of quantification was 10–20 ng/ml (RSD 4%) using a 0.5 ml plasma sample, and the inter assay precision was 3–10% over the concentration range 50 ng/ml to 20 μg/ml. Recovery from plasma was 81% (RSD 10%) over the range 10 ng/ml to 5 μg/ml. The method has been applied successfully to the analysis of several thousand samples from human pharmacokinetic studies. Care has to be taken to avoid exposure of samples to direct sunlight, and the use of opaque vessels for sample storage and handling is recommended.     

ETAAS determination of aluminium and copper in dialysis concentrates after microcolumn chelating ion-exchange preconcentration

A procedure was developed for the preconcentration and determination of aluminium and copper in dialysis concentrates at the ng cm^–3 level. The preconcentration was achieved on microcolumns filled with Chelex-100 resin adjusted to a pH of 4.0. Five repetitive cycles of the sample through the column ensured a sufficient contact time for quantitative retention of aluminium and copper ions. The retained ions were eluted with HNO₃ (0.5 mol dm^–3). Aluminium and copper were determined in the eluate by Zeeman ETAAS using the standard addition technique. The procedure was performed under clean room conditions (class 10,000), The reliability of the results was evaluated by recovery tests, using dialysis concentrates spiked with aluminium and copper. The recoveries obtained ranged from 86 to 106% for aluminium and from 92 to 97% for copper. Using the recommended procedure, the LOD of aluminium and copper in dialysis concentrates (preconcentration factor 2) was found to be 0.5 ng cm^–3 and 0.2 ng cm^–3, respectively. Received: 19 December 1997 / Revised: 10 March 1998 / Accepted: 28 March 1998     

Evaluation of Fluorescamine as a Phosphogenic Derivatizing Reagent of Primary Amines

Abstract

Fluorescamine has been shown to be a promising derivatizing reagent for the room temperature phosphorescence analysis of primary amino acids. The fluorescamine concentration used for derivatization in solution was 600 μg/ml and for direct derivatization, 1160 μg/ml. For derivatized primary amino acids the limits of detection were found to be between 0.8 ng and 2.9 ng with linear dynamic ranges between 2 and 3 orders of magnitude.     

Determination of Ciprofloxacin (Bay o 9867) in Biological Fluids by High-Performance Liquid Chromatography

Abstract

A high-performance liquid chromatographic method for the analyses of ciprofloxacin (BAY o 9867) (1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid hydrochloride) in human serum, plasma and urine samples is described. Diluted serum, plasma, and urine samples are injected onto a RP-18 column without prior extraction or clean-up procedure. Ciprofloxacin is separated from the ballast by an eluent consisting of an 0.025M H₃PO₄ solution adjusted to pH=3 with tetrabutylammonium hydroxide and acetonitrile.

Ciprofloxacin is detected fluorimetrically giving a detection limit of 8ng/ml in plasma and serum and of 50ng/ml in urine. A statistical evaluation of the assay showed acceptable accuracy and precision for 10 to 500ng of BAY o 9867 per ml in serum and plasma and for 50ng to 600ng of BAY o 9867 per ml of diluted urine specimens. This method was used to monitor the concentrations of BAY o 9867 in serum, plasma and urine of volunteers after oral administration of ciprofloxacin.     

Revised HPLC Determination of Atenolol in Plasma and Urine

Abstract

An HPLC method for analysis of atenolol in human plasma and urine is presented. Based on alkaline extraction, acid backextraction and reverse phase ion-pair chromatography this method is quite specific for atenolol. For a 0.5 ml plasma sample the sensitivity ranges from 20 ng/ml in fasted healthy volunteers to 50 ng/ml in various groups of patients. A sensitivity in urine of 1.0 mcg/ml was sufficient for all samples studied. As presented this method has been used in several clinical pharmacokinetic studies involving hundreds of samples.     

Simultaneous determination of beryllium and aluminium in mixtures using derivative spectrophotometry

The spectrophotometric determination of beryllium and aluminium with 5,8-dihydroxy-1,4-naphthoquinone in the presence of a non-ionic surfactant is reported. Absorption maxima, molar absorptivity and Sandell's Sensitivity of 1:2 (M:L) beryllium and aluminium complexes are, 585 nm and 598 nm, 1.63 x 10(4) l.mole(-1).cm(-1) and 2.04 x 10(4) l.mole(-1).cm(-1), and 0.55 ng/cm(2) and 1.32 ng/cm(2) respectively. Beer's law is obeyed between 7.20-3.96 x 10(2) ng/ml beryllium and 1.08 x 10(1)-1.08 x 10(3) ng/ml aluminium. A method for simultaneous determination of beryllium and aluminium in their mixture using derivative spectra is described. The range 3.6 x 10(1)-3.6 x 10(2) ng/ml beryllium could be determined in the presence of 1.08 x 10(2)-1.08 x 10(3) ng/ml aluminium, and vice versa.     

Sequential Extraction-Spectrofluorimetric Determination of Lead and Mercury Using Cryptand Ethers

Abstract

A spectrofluorimetric method for the determination of ultratrace amounts of lead and mercury is described based on the sequential extraction of the ternary ion-association complexes formed between the cation, a cryptand as the ligand and eosin as counter ion. A linear working range from the detection limit (9 ng/ml) to 250 ng/ml of lead and 12 ng/ml of mercury was obtained.

The relative standarddeviation was 3.5 % – 2.1 %. We propose that this method could be used routinely to control lead and mercury simultaneous.     

High Performance Liquid Chromatoraphic Determination of R-831, A New Antiallergic Agent,in Dogs and Humans

Abstract

A simple, selective and sensitive HPLC method has been developed to measure R-831 levels in dogs and humans. It is an internal standard technique with a single step extraction and one wash. Samples are chromatographed on a reversed-phase system with ultraviolet detection. The lowest detectable concentration for plasma is 25 ng R-831/ml with a 1 ml sample and the linear range is 25–8000 ng R-831/ml. The lowest detectable concentration for urine is 250 ng R-831/ml with a 0.1 ml sample and the linear range is 250–8000 ng R-831/ml. This method has been used to quantitate levels of R-831 in bioavailability and toxicity studies in dogs, and in pharmacokinetic and efficacy studies in humans.     

A New Method for the HPLC Analysis of Pt(II) in Urine

Abstract

An analytical method has been developed to measure Pt(II) in urine via derivatization and UV or HPLC analysis. A measured quantity of urine is heated briefly with diethyl ammonium diethyl-dithiocarbamate, and the resulting Pt(Et₂NCS₂)₂ is extracted into a measured volume of chloroform. Concentrations of Pt(II) are determined by UV absorption at 346 nm or by reverse phase HPLC analysis. The detection limit for Pt(II) as its dithiocarbamate is ～ 1 ng by HPLC; the concentration limit for HPLC analysis by direct extraction was ～ 25 ng/ml. Chromatographic response was linearly related to Pt(II) concentration over the range 100-4, 000 ng/ml; dilution of more concentrated samples has extended this range to at least 30, 000 ng/ml. This method has been applied to the analysis of Pt(II) in the urine of patients who have received cis-dichlorodiamniineplatinum(II) (CDDP) chemotherapy.     

Fluorometric Determination of Iron(Iii) with O-Hydroxyhydroquinonephthalein in the Presence of Brij 58

Abstract

A highly sensitive fluorescence reaction of iron(III) with o-hydroxyhydroquinonephthalein (Qnph) in the presence of various surfactants, and its application to the fluorophotometry of trace amounts of iron(III) is described. the method is based on the fluorescence quenching reaction between Qnph and iron(III) in the presence of Brij 58 at pH 3–4. the quenching calibration graph was linear over the range 0 – 300 ng per ml iron(III) by using fluorescence reaction at Em 525 nm with Ex 470 nm, and the iron(III) detection limit was 5 ng/ml. the proposed method is simple, rapid and does not involve heating or solvent extraction.     

Quantitation of Verapamil and Norverapamil in Small Blood Samples From the Rat by High Performance Liquid Chromatography

Abstract

A simple, sensitive HPLC assay using flurescence detection was developed for quantitation of verapamil and its active metabolite, norverapamil in 100-200 μl blood samples from the rat. Baseline separation of verapamil, normverapamil and internal standard, propranolol, was attained within 14 minutes. Standard curves for verapamil and norverapamil were linear from 7 ng/ml to 1000 ng/ml with limit of detection of 4 ng/ml for both Compounds. the intraday and interday coefficients of variation in verapamil and norverapamil concentrations, determined from spiked whole blood samples, were less than 10%.